1) fluoroquinolone resistance
氟喹诺酮抗性
1.
Our results strongly suggest that mutations of regulatory genes and the modulated expression of acrAB-tolC by the mar operon contribute to fluoroquinolone resistance and Mar phenotype,and the mutations of marR,soxR and acrR in the mutants correlated with fluoroquinolone resistance and Mar phenotype.
本研究结果表明沙门氏菌诱导株的调控基因突变和mar操纵子介导的acrAB-tolC的表达上调均贡献了沙门氏菌诱导株的氟喹诺酮抗性和Mar表型,且诱导株的marR,soxR和acrR基因突变与氟喹诺酮抗性和Mar表型具有相关性。
2) fluoroquinolones
氟喹诺酮
1.
Simultaneous Determination of Sulfonamides and Fluoroquinolones Residues in Pork by Solid-phase Extraction and High Performance Liquid Chromatography;
固相萃取-高效液相色谱法同时测定猪肉中磺胺类和氟喹诺酮类兽药残留量
2.
Interactions Between Fluoroquinolones and Bovine Serum Albumin by Fluorescence Method and Affinity Capillary Electrophoresis;
亲和毛细管电泳法和荧光法研究氟喹诺酮类药物与牛血清白蛋白的相互作用
3.
Mutant prevention concentration of fluoroquinolones for Baumannii acinetobacter and its ciprofloxacin induced mutant strains;
氟喹诺酮类药物对鲍曼不动杆菌及其环丙沙星诱导突变株的防耐药突变浓度
3) fluroquinolone
氟喹诺酮
1.
The action mechanism of DNA Gyrase with the tittled compounds,selection and the structure- activity relationships of fluroquinolones are reviewed.
氟喹诺酮类药物具有广谱抗菌活性 ,本文就其与 DNA促旋酶作用机制、选择性及药物的构效关系作一简要综
2.
Objective Shigellosis was investigated among outpatients with diarrhea in Wuhan, serotype distribution and drug resistance of Shigellae was analyzed, the mechanism of fluroquinolones-resistant was studied and a genotyping method for Shigella spp.
目的和意义 通过调查武汉市2004年流行季节门诊腹泻患者志贺菌感染状况,分析志贺菌血清型分布及耐药现状,并与2003年做相关比较,研究志贺菌中氟喹诺酮作用靶位点的改变导致氟喹诺酮耐药的机制,并用分子生物学方法对志贺菌进行基因分型,为志贺菌耐药性监测、临床合理用药、新药和疫苗开发及流行病学研究提供理论依据。
4) Fluoroquinolone
氟喹诺酮
1.
Relation between fluoroquinolones-resistant and mutation of grlA and grlB gene in Staphylococcus aureus;
金黄色葡萄球菌氟喹诺酮的耐药性与grlA、grlB突变的关系
2.
Synthesis and antibacterial activities of 7-{4-[2-[2-substituted-4-((5S)-5-acetylaminomethyl-2-oxo-oxazolidin-3-yl)-phenyl]-ethyl]-piperazin-1-yl}-fluoroquinolones;
7-{4-[2-[2-取代-4-((5S)-5-乙酰胺甲基-2-氧代-噁唑烷-3-基)苯基]乙基]哌嗪-1-基}-氟喹诺酮类化合物的合成与抗菌活性
3.
A Study on the Difference of Efflux Protein Expression between Klebsiella Pneumoniae Used in Vitro Fluoroquinolone and Ones Not Used;
氟喹诺酮体外诱导肺炎克雷伯菌外排蛋白表达差异的研究
5) Fluoroquinolones
氟喹诺酮类抗菌药
1.
Progress about Drug Fast Mechanism of Enterococcus to Fluoroquinolones;
肠球菌对氟喹诺酮类抗菌药物耐药机制研究进展
6) Fluoroquinolones
氟喹诺酮类抗菌药物
1.
These new fluoroquinolones provide more choice for clinical doctors to treat infection patients, but we should use these fluoroquinolones reasonably in order to avoide bacteria resistance producing and the interaction between drugs.
为避免细菌耐药性产生,及药物间相互作用,本文对如何合理应用氟喹诺酮类抗菌药物及临床用药特点做一综述。
补充资料:格列喹酮
分子式:C27H33N3O6S
分子量:暂无
CAS号:33342-05-1
性质:暂无
制备方法:暂无
用途:降血糖药,用于非胰岛素依赖型糖尿病药。
分子量:暂无
CAS号:33342-05-1
性质:暂无
制备方法:暂无
用途:降血糖药,用于非胰岛素依赖型糖尿病药。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条